Chronix Biomedical and University of Göttingen Receive NACB Distinguished Abstract Award for Early Detection Method of Organ Transplant Rejection
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
HOUSTON & GÖTTINGEN, Germany--(BUSINESS WIRE)--Researchers from the University Medical Center Göttingen and Chronix Biomedical announce they have received a National Academy of Clinical Biochemistry (NACB) Distinguished Abstract Award for their paper titled “Rapid and Cost Effective Measurement of Circulating Cell Free Graft DNA for the Early Detection of Liver Transplant Rejection.” The paper is based on a pilot study led by Michael Oellerich, M.D., FACB, FRCPath and Lower Saxony Distinguished Professor of Clinical Chemistry at the University Medical Center Göttingen, which demonstrated the utility of cell-free DNA (cfDNA) detected through a blood test as a biomarker to monitor organ transplant rejection.
Help employers find you! Check out all the jobs and post your resume.
HOUSTON & GÖTTINGEN, Germany--(BUSINESS WIRE)--Researchers from the University Medical Center Göttingen and Chronix Biomedical announce they have received a National Academy of Clinical Biochemistry (NACB) Distinguished Abstract Award for their paper titled “Rapid and Cost Effective Measurement of Circulating Cell Free Graft DNA for the Early Detection of Liver Transplant Rejection.” The paper is based on a pilot study led by Michael Oellerich, M.D., FACB, FRCPath and Lower Saxony Distinguished Professor of Clinical Chemistry at the University Medical Center Göttingen, which demonstrated the utility of cell-free DNA (cfDNA) detected through a blood test as a biomarker to monitor organ transplant rejection.
Help employers find you! Check out all the jobs and post your resume.